Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
about
Hodgkin's disease and the Epstein-Barr virus.Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosisIdentification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigensCytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patientsSimultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"Novel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccineHuman CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivoHLA class I supertypes: a revised and updated classification.Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expressionDual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in ChinaThe immunology of Epstein-Barr virus infectionEx vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions.Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.HLA associations with nasopharyngeal carcinoma.Nasal NK/T-cell lymphoma: epidemiology and pathogenesisAssessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function.Generating functional CD8+ T cell memory response under transient CD4+ T cell deficiency: implications for vaccination of immunocompromised individuals.Potential selection of LMP1 variants in nasopharyngeal carcinoma.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.Chimerically fused antigen rich of overlapped epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a potential vaccine and diagnostic agentPeptide epitope identification for tumor-reactive CD4 T cells.Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.Viral miRNAs and immune evasionThe interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses.Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2.The B subunit of Escherichia coli heat-labile enterotoxin enhances CD8+ cytotoxic-T-lymphocyte killing of Epstein-Barr virus-infected cell lines.TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants.Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma.An asymmetric model of heterozygote advantage at major histocompatibility complex genes: degenerate pathogen recognition and intersection advantageImmune parameters to consider when choosing T-cell receptors for therapy.HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.Generating CTLs against the subdominant EBV LMP antigens by transient expression of an A20 inhibitor with EBV LMP proteins in human DCs.Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy.
P2860
Q24535291-1B9FA0CA-0913-4D28-BB86-5FB1870D9F1AQ24657081-C94DCB4A-0BBB-4B8B-873A-081AE4F4B195Q24673417-F79D8303-11B1-45C7-878C-F4A3C1DE4993Q24800020-EE6634A1-605E-45E8-BDF4-3E823C739476Q24814428-7D2F41E9-EF00-4A07-AC57-73BE54F745DFQ28749468-10CD7803-FC6D-4701-A313-DCD7D65A85B3Q30442797-FC620FF0-643C-43A7-B427-1D06A05B65E0Q31090571-D2B29FE6-26D8-483E-A8D7-E5298E716D5CQ33315730-C6D5AE0E-BFE3-43F8-833B-AD5ADF5F8FB8Q33783532-62515FE8-FE55-407B-A7CB-0402F76D96E3Q33894929-9613B43A-EE8F-4894-8960-821A8F568857Q34166497-E15DCB71-1F0E-44AD-8810-51A01BBB4C8BQ34225567-E530A0B2-6A86-445D-B80B-3C526E4DB26EQ35149684-B08ED8A2-D9F1-4891-85C1-401A04805AD1Q35621782-847A0D37-4412-4F5D-892B-44C841B4DB15Q36125265-378DB44C-048D-4D0F-BA64-78AF1A43A8E1Q36511890-47FDBDE0-5577-464A-BC66-CCD96E8AEDC1Q36623027-829DFD92-D1B8-48B1-A880-B322A02444D1Q36641073-C3A62289-0907-4CE6-BE7C-86A9B5A31BDCQ36782485-8ECCBD85-2921-4F1C-8E86-8958E2C5AE01Q36944141-6F9E7622-9A1B-4745-AD46-1C06468B3297Q37016499-28F86F2A-DE34-42DF-A63E-F1C0930D4A34Q37101134-9859D8E4-53C1-47FB-9E69-B630E838D626Q37171413-AA9ED6C2-187C-4E43-BED5-B067695FD671Q37387851-61CF0722-F95C-4962-B316-9A70F20B65DCQ37901174-F6F2E1F2-FF17-4BEB-BC69-40F7F7E75A6BQ38264787-103EDDDA-5250-4536-8899-A792A7A90E67Q39607047-4AE19B53-814E-4E18-B3DC-413EB094707CQ39700355-3D48BFE9-BD5A-4B9C-A1F9-651DB547D9DDQ39736862-C1AC2F5D-6959-4A32-A649-80014A14FC24Q40064164-0B0CBEB3-C455-4D36-92DD-8B270B6D365FQ40851412-FA1842B5-8635-4D46-A0F2-CCE2A5604061Q42084853-DB43A5DE-39E3-41EC-A877-B9927779B06CQ42129294-6F22300A-41FC-4E29-AD54-3C0BB0D48DC9Q42598828-EC567784-2436-4174-9744-167EB5DDD633Q42632595-2E15E714-25FC-4797-B11E-104B24714BE4Q42937211-8FB66460-188B-4540-A25F-2A726820EA8FQ47549907-B789F881-56CE-4041-88C9-28894089BA4D
P2860
Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Identification of cytotoxic T ...... cific cytotoxic T lymphocytes.
@en
type
label
Identification of cytotoxic T ...... cific cytotoxic T lymphocytes.
@en
prefLabel
Identification of cytotoxic T ...... cific cytotoxic T lymphocytes.
@en
P2093
P1476
Identification of cytotoxic T ...... cific cytotoxic T lymphocytes.
@en
P2093
Burrows SR
Nicholls J
Poulsen LM
P304
P356
10.1002/(SICI)1521-4141(199802)28:02<451::AID-IMMU451>3.3.CO;2-L
P407
P50
P577
1998-02-01T00:00:00Z